Despite adverse event risk, anti psychotic polypharmacy has continued to rise
Year: 2025
Type: article
DOI: 10.1002/pu.31298
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408975347
